Abiopharma

🔍 Koonin Steven R (Executive)

Company: TKO Group Holdings, Inc. (TKO)

Report Date: 2026-06-10

Detailed Transactions and Holdings:

• Acquired 1,753 shares of Class A Common Stock (Direct)
  Date: 2026-06-10 | Code: M | equity_swap_involved: false | shares_owned_after: 11,153.00 | transaction_form_type: 4
• Sold 1,753 shares of Restricted Stock Unit (Derivative)
  Date: 2026-06-10 | Code: M | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F2, F2
• Acquired 1,549 shares of Restricted Stock Unit (Derivative)
  Date: 2026-06-10 | Code: A | equity_swap_involved: false | shares_owned_after: 1,549.00 | transaction_form_type: 4 | Footnotes: F1, F3, F3

Footnotes:

• F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock of the Issuer.
• F2: The RSUs vested on the date of the Issuer's annual stockholder meeting, which was held on June 10, 2026.
• F3: The RSUs will vest on the date of the Issuer's next annual stockholder meeting immediately following the date of grant.